Augmentation of Limb Perfusion With Contrast Ultrasound
| Status: | Recruiting |
|---|---|
| Conditions: | Peripheral Vascular Disease |
| Therapuetic Areas: | Cardiology / Vascular Diseases |
| Healthy: | No |
| Age Range: | 19 - 99 |
| Updated: | 8/25/2018 |
| Start Date: | June 18, 2018 |
| End Date: | December 2019 |
| Contact: | Jonathan R Lindner, MD |
| Email: | lindnerj@ohsu.edu |
| Phone: | 5034943574 |
Our laboratory has discovered that ultrasound (US) imaging together with clinically approved
microbubble ultrasound contrast agents can augment limb tissue perfusion. These observations
have been made in mice with and without peripheral artery disease (PAD), and also in humans
where high power contrast enhanced ultrasound (CEU) was used to measure perfusion but was
found also to augment perfusion by almost 2-fold. The latter human studies were performed
with ultrasound protocols designed for perfusion imaging and not for flow augmentation. In
this study, we will measure the degree to which limb perfusion is augmented with specific
therapeutic CEU settings that are still within the FDA-approved limits with regards to US
power and contrast dosing.
microbubble ultrasound contrast agents can augment limb tissue perfusion. These observations
have been made in mice with and without peripheral artery disease (PAD), and also in humans
where high power contrast enhanced ultrasound (CEU) was used to measure perfusion but was
found also to augment perfusion by almost 2-fold. The latter human studies were performed
with ultrasound protocols designed for perfusion imaging and not for flow augmentation. In
this study, we will measure the degree to which limb perfusion is augmented with specific
therapeutic CEU settings that are still within the FDA-approved limits with regards to US
power and contrast dosing.
Inclusion Criteria:
- Age ≥18 y.o.
- For PAD subjects: known history of unilateral or bilateral PAD diagnosed by reduced
ankle-brachial index or angiography and a Rutherford symptom class of 4-6.
Exclusion Criteria:
1. Major medical illness other than PAD affecting the limb (muscle disease, blood
diseases that influence flow or rheology, severe heart failure [NYHA class IV or LVEF
<30%]).
2. Pregnant or lactating females
3. Hypersensitivity to any ultrasound contrast agent
4. Known atrial septal defect or large right to left shunt.
5. Hemodynamic instability (hypotension with systolic BP <90 mm Hg, need for
vasopressors)
6. Evidence for ongoing myocardial ischemia
7. For normal controls, any known structural non-arrhythmic cardiovascular disease
(coronary artery disease, heart failure, moderate or greater valve disease).
We found this trial at
1
site
Click here to add this to my saved trials
